An observational study assessing the frequency, timing, and detailed motivation of stopping Dolutegravir containing antiretroviral regimens in HIV patients in a real life setting
Latest Information Update: 28 Oct 2016
At a glance
- Drugs Dolutegravir (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 28 Oct 2016 New trial record
- 24 Sep 2016 Results published in the AIDS